Top & Current
Tue, April 5, 2022
[ Tue, Apr 05th 2022
] - WOPRAI
[ Tue, Apr 05th 2022
] - WOPRAI
Fri, October 8, 2021
[ Fri, Oct 08th 2021
] - WOPRAI
Fri, August 20, 2021
[ Fri, Aug 20th 2021
] - WOPRAI
Thu, July 15, 2021
[ Thu, Jul 15th 2021
] - WOPRAI
Tue, July 13, 2021
[ Tue, Jul 13th 2021
] - WOPRAI
Thu, May 13, 2021
[ Thu, May 13th 2021
] - WOPRAI
Mon, December 14, 2020
[ Mon, Dec 14th 2020
] - WOPRAI
Thu, November 12, 2020
[ Thu, Nov 12th 2020
] - WOPRAI
Tue, November 10, 2020
[ Tue, Nov 10th 2020
] - WOPRAI
Mon, November 9, 2020
[ Mon, Nov 09th 2020
] - WOPRAI
Thu, September 10, 2020
[ Thu, Sep 10th 2020
] - WOPRAI
Tue, July 21, 2020
[ Tue, Jul 21st 2020
] - WOPRAI
Mon, July 13, 2020
[ Mon, Jul 13th 2020
] - WOPRAI
Thu, April 30, 2020
[ Thu, Apr 30th 2020
] - WOPRAI
Fri, April 3, 2020
[ Fri, Apr 03rd 2020
] - WOPRAI
Mon, February 24, 2020
[ Mon, Feb 24th 2020
] - WOPRAI
Tue, May 21, 2019
[ Tue, May 21st 2019
] - WOPRAI
Wed, August 15, 2018
[ Wed, Aug 15th 2018
] - WOPRAI
Fri, June 29, 2018
[ Fri, Jun 29th 2018
] - WOPRAI
Thu, March 29, 2018
[ Thu, Mar 29th 2018
] - WOPRAI
Wed, September 20, 2017
[ Wed, Sep 20th 2017
] - WOPRAI
Thu, August 3, 2017
[ Thu, Aug 03rd 2017
] - WOPRAI
Fri, August 5, 2016
Arlinda Lee Maintained (XFOR) at Strong Buy with Decreased Target to $10 on, Apr 5th, 2022
Arlinda Lee of Canaccord Genuity, Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy with Decreased Target from $20 to $10 on, Apr 5th, 2022.
Arlinda has made no other calls on XFOR in the last 4 months.
There is 1 other peer that has a rating on XFOR. Out of the 1 peers that are also analyzing XFOR, 0 agree with Arlinda's Rating of Hold.
This is the rating of the analyst that currently disagrees with Arlinda
- Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $11 on, Tuesday, December 14th, 2021